Indrayani Biotech declares Audited FY26 results

Indrayani Biotech Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results during a meeting held on August 17, 2026. The company will publish the results in newspapers and on its website, as well as the BSE website. The auditor's report includes a qualified opinion due to uncertainties regarding confirmation and reconciliation of certain balances, and consolidation of subsidiaries under Indian GAAP instead of IND AS, with an unascertainable impact on the profit and loss account.